Guanidino phenylalanin compounds used as urokinase inhibitors
US7538216B2 · kind B2 · utility
6Cited by
1References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 5, 2003 |
| Grant date | May 26, 2009 |
| Priority date | — |
| Expiry date | Jun 5, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/215
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of derivatives of 3-guanidinophenylalanine as urokinase inhibitors for treating malignant tumors and metastasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.